Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, January 31, 2015
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Beating The Clock: New Treatment For Rabies Developed
University of Georgia researchers have developed a new treatment for rabies.
Utilizing Fast HPLC Screening Methods for the Detection of Steroids
Analysis of steroids improved by choosing the optimal HPLC column for the separation.
New Approach May Lead to Inhalable Vaccines
The approach using nanoparticles could lead to development of inhalable vaccines for influenza, pneumonia and tuberculosis.
New Mouse Study Method Enables Comparative Vaccine Studies for Tularemia
The study appears online in Clinical Vaccine and Immunology.
Oxford Vaccine Group Begins First Trial of New Ebola Vaccine
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).
UMMS Receives $6.1 M to Develop Model for Predicting Gene Expression
Insight into regulation of the genes that allow the immune system to recognize pathogens will help scientists rationally design new vaccines and prevent autoimmunity.
GRP78 Protein Possible Universal Therapeutic Target
Drug combination including Viagra is effective tool in targeting the protein.
Adapting Influenza for Vaccine Mass Production
The ability to grow influenza in cell culture rather than chicken eggs paves the way for mass production of the vaccine.
How to Achieve High-Speed, High-Resolution Glycan Mapping for mAb Characterization
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern.
Closing in on ‘Holy Grail’ of HIV Vaccine
Researchers describe a way to induce long-sought broadly neutralizing antibodies.

Continuous Chromatography (MCSGP) for the Purification of Therapeutic Proteins
Dr Thomas Müller-Späth, ETH Switzerland, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Biosimilars and the US-legislation: Analytical and Clinical Challenges
Dr William Egan, Vice President in the Consulting Division of PharmaNet, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Actionable Biomarkers for Rheumatoid Arthritis
Dr William Robinson, Stanford University, speaking at Microarray World Congress 2011.

Background and Key Drivers Leading to Clinical Immunogenicity
Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.

Thinking Small so as to Gain the Bigger Picture: Progress in High Throughput Bioprocess Development
Professor Nigel Titchener-Hooker, University College London, speaking at Bioprocessing, Biologics and Biotherapeutics Congress 2011.

Antibody Fragments - New Approaches for Production
Dr John Lidell, FujiFilm, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

EU Regulatory Landscape for Approval of Biosimilars
Dr Lincoln Tsang, Arnold and Porter LLP, speaking at BioProcessing, Biologics & Biotherapeutics Congress / Stem Cells Europe 2011.

Modeling and Prediction of Antibody Chromatography Purification
Professor Christian Frech, Mannheim University of Applied Science, speaking at BioProcessing, Biologics and Biotherapeutics Congress.

Host Cell Protein Interactions During the Recovery of Monoclonal Antibodies
Dr Daniel Bracewell, University College London, speaking at BioProcessing, Biologics and Biotherapeutics Congress 2011.

<< 1 2 3 >>
Showing Results 21 - 30 of 30
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn